In vitro activity of gepotidacin against urine isolates of Escherichia coli from outpatient departments in Germany.

Gepotidacin showed promising in vitro activity against urine isolates of E. coli, including ciprofloxacin-resistant isolates, ESBL-producing isolates and isolates resistant to oral standard-of-care antibiotics.